Drug Development

Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia!

QPS CEO Ben Chien has made it through to the round of 30 (31, actually) being considered for this year’s prestigious EY Entrepreneur Of The Year Award for the Greater Philadelphia area. The only competitive awards program in the world for entrepreneurs and leaders of high-growth companies, the 30 year-old program operates in 145 cities […]

Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia! Read More »

QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients

Cannabinoid bioscience has come a long way. New York-based Axim Biotech is at the forefront, developing – among many other, related products – a multi-layered, slow-release cannabinoid chewing gum. Not for the candy stand, MedChewRx® is seeking FDA and EMA approval for the treatment of pain and spasticity associated with multiple sclerosis. Characteristically, QPS is

QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients Read More »

Fast Track Routes for Medicines that address Unmet Medical Needs

Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorization The European Medicines Agency (EMA) has revised its guidelines on the implementation of accelerated assessment and conditional marketing authorization, two key tools in the European legislation to accelerate patients’ access to medicines that address unmet medical needs. Accelerated assessment and

Fast Track Routes for Medicines that address Unmet Medical Needs Read More »

Regulatory Expertise Now Part of QPS Clinical Development Offerings

In July 2015, regulatory expert Patricia Baede joined QPS’ clinical development teams. With 20 years of experience in clinical trial conduct and all regulatory aspects of drug development, Baede adds EU regulatory support to the growing portfolio of clinical activities QPS provides. In the past, she has worked on drug development teams as Phase I

Regulatory Expertise Now Part of QPS Clinical Development Offerings Read More »

Scroll to Top